ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Cancergrams Cost $840 Year For All

December 2, 1977

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Robert Day Named New Director At Hutchinson Center

June 19, 1981

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Varmus Appoints Group On Intellectual Property

May 8, 1998

Karmanos Cancer Center Wins $4.6M From U.S. Army.

September 5, 2008